Aurora Cannabis said: In Q3 fiscal 2024, the company expects cannabis net revenue to be largely similar to fiscal Q2 2024, with the geographical mix slightly weighted further towards the international medical segment. For plant propagation, we expect to see seasonally reduced revenues and gross profit in fiscal Q3 2024 that will be consistent with fiscal Q2 2024 and in line with historical performance. Aurora’s achievement of significant and sustainable operating cost and SG&A reductions has now resulted in four consecutive quarters with positive Adjusted EBITDA. This has paved the path towards positive free cashflow in calendar year 2024.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ACB:
- Aurora Cannabis Announces Fiscal 2024 Second Quarter Results and Delivers Record Positive Adjusted EBITDA
- Aurora Cannabis options imply 15.6% move in share price post-earnings
- Rising High: Exclusive talk with coca leaf company Harbour Coca
- Options Volatility and Implied Earnings Moves Today, November 09, 2023
- Rising High: Exclusive talk with venture capital firm Safe Supply